If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Retevmo ® (selpercatinib) capsules
40 mg, 80 mgThis information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Selpercatinib is taken orally twice daily until disease progression or unacceptable toxicity. The recommended dose of selpercatinib based on actual body weight is detailed in Recommended Selpercatinib Dosage.1
1Retevmo [package insert]. Indianapolis, IN: Eli Lilly and Company; 2021.
G-tube = gastrostomy tube
Lilly = Eli Lilly and Company
Date of Last Review: January 04, 2021
If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.
Available Mon - Fri, 9am - 7pm EST